Multicenter study to assess the ...
Multicenter study to assess the use of BL-DetecTool for the detection ...
The assessed rapid assay to detect CTX-M beta-lactamases and carbapenemases directly from clinical samples can favor in the rapid detection ...
Randomized, Multicenter Study to Assess the Effects of Different ...
Sildenafil at 80 mg was noninferior to sildenafil at 5 mg when examining all-cause mortality in adults with PAH. Secondary efficacy end points favored 80 mg of ...
A Modular Phase I/II, Open-label, Multicenter Study to Assess the ...
The main purpose of the study is to assess the safety and tolerability of AZD9829 in different dose levels for patients with hematological malignancies.
A phase 3, multicenter study to assess the 1-year safety and ...
OLZ/SAM was generally well tolerated over 52 weeks. Weight, waist circumference, metabolic laboratory parameters, and schizophrenia symptoms remained stable ...
A phase I/II open label, multicenter study to assess the safety ...
HB0028 was generally well tolerated, and therapy provided modest antitumor activity in patients with heavily pretreated advanced solid tumors.
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and ...
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET.
A Phase I/II, Open-Label, Multicenter Study to Assess the Safety ...
This study will treat patients with advanced NSCLC with EGFR or HER2 mutation who have progressed following prior therapy. This is the first time this drug ...
A phase I multicenter study to assess the safety, tolerability, and ...
mRNA-4157 is a lipid encapsulated personalized vaccine encoding multiple neoantigens selected using a proprietary algorithm designed to induce neoantigen ...
A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and ...
The purpose of the study is to learn if the study drug, P1101 (Ropeginterferon alfa-2b-njft) can normalize blood counts. The safety of P1101 will also be ...
A Modular Phase I/II, Open-Label, Multicenter Study to Assess the ...
This project is being done to learn more about AZD9829 [study drug] and also to better understand the studied disease and associated health problems.
Clinical Trials - Cleveland Clinic
randomized, double-blind, placebo controlled, multicenter study to assess the efficacy and safety of a 12-week administration of OATD-01, an oral inhibitor ...
NCT01223352 - The YODA Project
An Open-label, Prospective Multicenter Study to Assess the Pharmacokinetics, Tolerability, Safety and Efficacy of the Pediatric Formulation of Bosentan Two ...
1154TiP A randomized, prospective, multicenter study to assess the ...
We hypothesize that the early diagnosis of brain mets will improve the symptomatic brain mets free survival (SBMFS) in pts with previously untreated, ...
172 A Phase 3, Multicenter Study to Assess the Long-Term Safety ...
172 A Phase 3, Multicenter Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Olanzapine/Samidorphan in Patients with ...
A Multicenter Study to Assess a Systematic Screening of ... - MDPI
Occupational lung cancer cases remain largely under-reported and under-compensated worldwide. In order to improve the detection and ...
A Prospective, Multicenter Study to Assess the Safety and Efficacy of ...
This study was designed to assess the safety and efficacy of TLNS plus targeted physical therapy (PT) in people with a chronic balance deficit after mild-to- ...
Clinical Research Studies - NYU
A Phase 1/2a Multicenter Open-Label First in Human Study to Assess the Safety Tolerability Pharmacokinetics and Preliminary Antitumor Activity of DB-1303 in ...
A Randomized, Double-blind, Placebo-controlled Multicenter Study ...
This project is being done to test the effectiveness of lenrispodun to reduce involuntary muscle movements in participants with Parkinson's disease as well ...
A Randomized, Double-blind, Placebo-controlled, Multicenter Study ...
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of Bosentan in Patients With Mildly ...
A Phase IIIb, Single-Arm, Multicenter Study to Assess Efficacy ...
A Phase IIIb, Single-Arm, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Ropeginterferon alfa-2b-njft (P1101) in Adult Patients with ...